These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19833372)

  • 1. The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus.
    Suguitan AL; Marino MP; Desai PD; Chen LM; Matsuoka Y; Donis RO; Jin H; Swayne DE; Kemble G; Subbarao K
    Virology; 2009 Dec; 395(2):280-8. PubMed ID: 19833372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model.
    Sun W; Wang Z; Sun Y; Li D; Zhu M; Zhao M; Wang Y; Xu J; Kong Y; Li Y; Feng N; Wang T; Zhao Y; Yang S; Gao Y; Xia X
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
    Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
    PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
    Fan S; Gao Y; Shinya K; Li CK; Li Y; Shi J; Jiang Y; Suo Y; Tong T; Zhong G; Song J; Zhang Y; Tian G; Guan Y; Xu XN; Bu Z; Kawaoka Y; Chen H
    PLoS Pathog; 2009 May; 5(5):e1000409. PubMed ID: 19412338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals.
    Suguitan AL; Matsuoka Y; Lau YF; Santos CP; Vogel L; Cheng LI; Orandle M; Subbarao K
    J Virol; 2012 Mar; 86(5):2706-14. PubMed ID: 22205751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
    Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
    Joseph T; McAuliffe J; Lu B; Vogel L; Swayne D; Jin H; Kemble G; Subbarao K
    Virology; 2008 Aug; 378(1):123-32. PubMed ID: 18585748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.
    Shi S; Chen S; Han W; Wu B; Zhang X; Tang Y; Wang X; Zhu Y; Peng D; Liu X
    Vaccine; 2016 Jan; 34(3):350-7. PubMed ID: 26638027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
    Karron RA; Talaat K; Luke C; Callahan K; Thumar B; Dilorenzo S; McAuliffe J; Schappell E; Suguitan A; Mills K; Chen G; Lamirande E; Coelingh K; Jin H; Murphy BR; Kemble G; Subbarao K
    Vaccine; 2009 Aug; 27(36):4953-60. PubMed ID: 19540952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
    Steel J; Lowen AC; Pena L; Angel M; Solórzano A; Albrecht R; Perez DR; García-Sastre A; Palese P
    J Virol; 2009 Feb; 83(4):1742-53. PubMed ID: 19073731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
    Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
    J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.
    Jang YH; Jung EJ; Byun YH; Lee KH; Lee EY; Lee YJ; Seong BL
    Vaccine; 2013 Jul; 31(33):3339-46. PubMed ID: 23742997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin.
    Lee YJ; Jang YH; Kim P; Lee YH; Lee YJ; Byun YH; Lee KH; Kim K; Seong BL
    Virology; 2016 Apr; 491():1-9. PubMed ID: 26874012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.